These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Identification of polyphenols from Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2021 Oct; 39(17):6747-6760. PubMed ID: 32762411 [TBL] [Abstract][Full Text] [Related]
45. Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation. Prajapati J; Patel R; Goswami D; Saraf M; Rawal RM Comput Biol Med; 2021 Aug; 135():104568. PubMed ID: 34174757 [TBL] [Abstract][Full Text] [Related]
46. Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease. Edache EI; Uzairu A; Mamza PA; Shallangwa GA; Yagin FH; Abdel Samee N; Mahmoud NF Front Mol Biosci; 2023; 10():1254230. PubMed ID: 37771457 [TBL] [Abstract][Full Text] [Related]
48. In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins. Elmaaty AA; Darwish KM; Khattab M; Elhady SS; Salah M; Hamed MIA; Al-Karmalawy AA; Saleh MM J Biomol Struct Dyn; 2022; 40(19):8866-8893. PubMed ID: 33928870 [TBL] [Abstract][Full Text] [Related]
49. Discovery of a "Cocktail" of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. ("Lagundi"). Cayona R; Creencia E Med Chem; 2022; 18(3):364-381. PubMed ID: 34148541 [TBL] [Abstract][Full Text] [Related]
50. Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus Abouelela ME; Assaf HK; Abdelhamid RA; Elkhyat ES; Sayed AM; Oszako T; Belbahri L; El Zowalaty AE; Abdelkader MSA Molecules; 2021 Mar; 26(6):. PubMed ID: 33801151 [TBL] [Abstract][Full Text] [Related]
51. In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2. Bhattacharya K; Bordoloi R; Chanu NR; Kalita R; Sahariah BJ; Bhattacharjee A J Genet Eng Biotechnol; 2022 Mar; 20(1):43. PubMed ID: 35262828 [TBL] [Abstract][Full Text] [Related]
52. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation. Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630 [TBL] [Abstract][Full Text] [Related]
53. Potential inhibitors of the main protease of SARS-CoV-2 and modulators of arachidonic acid pathway: Non-steroidal anti-inflammatory drugs against COVID-19. Sisakht M; Solhjoo A; Mahmoodzadeh A; Fathalipour M; Kabiri M; Sakhteman A Comput Biol Med; 2021 Sep; 136():104686. PubMed ID: 34340125 [TBL] [Abstract][Full Text] [Related]
54. Repositioning of anti-dengue compounds against SARS-CoV-2 as viral polyprotein processing inhibitor. Bajrai LH; Faizo AA; Alkhaldy AA; Dwivedi VD; Azhar EI PLoS One; 2022; 17(11):e0277328. PubMed ID: 36383621 [TBL] [Abstract][Full Text] [Related]
55. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease. Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685 [TBL] [Abstract][Full Text] [Related]
56. Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection. Xu Z; Zou Y; Gao X; Niu MM; Li J; Xue L; Jiang S Front Pharmacol; 2022; 13():1041331. PubMed ID: 36339564 [TBL] [Abstract][Full Text] [Related]
57. Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2. Shode FO; Idowu ASK; Uhomoibhi OJ; Sabiu S J Biomol Struct Dyn; 2022 Sep; 40(14):6587-6602. PubMed ID: 33590806 [TBL] [Abstract][Full Text] [Related]
58. Exploring the inhibition mechanism of SARS-CoV-2 main protease by ebselen: A molecular docking, molecular dynamics simulation and DFT approach. You W; Chen Y J Comput Chem; 2023 Oct; 44(26):2086-2095. PubMed ID: 37357616 [TBL] [Abstract][Full Text] [Related]
59. Amentoflavone derivatives significantly act towards the main protease (3CL Dey D; Hossain R; Biswas P; Paul P; Islam MA; Ema TI; Gain BK; Hasan MM; Bibi S; Islam MT; Rahman MA; Kim B Mol Divers; 2023 Apr; 27(2):857-871. PubMed ID: 35639226 [TBL] [Abstract][Full Text] [Related]
60. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study. Wakchaure PD; Ghosh S; Ganguly B J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]